Systematic review and meta-analysis of belatacept versus calcineurin inhibitors on risk of post-transplant diabetes mellitus in kidney transplant recipients

BackgroundThe novel immunosuppressant belatacept demonstrates a unique mechanism of action that significantly improves renal function and reduces metabolic complications. However, systematic evidence comparing the risk of post-transplant diabetes mellitus (PTDM) and overall safety profiles between b...

Descrición completa

Detalles Bibliográficos

Principais autores:	Xuchuan Wang, Dandan Song, Shufu Hou, Aiju Liu, Jing Gao, Lei Liu
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2026-02-01
Series:	Frontiers in Immunology
Assuntos:	belatacept calcineurin inhibitors immunosuppressive agents kidney transplantation new-onset diabetes
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1615875/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!